Yuyu Pharma Inc (000227) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.77x

Yuyu Pharma Inc (000227) has a Cash Flow Reinvestment Rate of 1.77x as of September 2025, reinvesting ₩1.48 Billion (capex ₩1.46 Billion plus investments ₩-22.80 Million) from operating cash flow of ₩836.62 Million. Explore 000227 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.77x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.48 Billion
Capex + Investments

Operating Cash Flow

₩836.62 Million
KRW

Capital Expenditures

₩1.46 Billion
KRW

Yuyu Pharma Inc Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Yuyu Pharma Inc across 8 annual periods. Also explore Yuyu Pharma Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Yuyu Pharma Inc (2014–2024)

Year-by-year capital reinvestment analysis for Yuyu Pharma Inc. For live market cap and broader valuation context, see Yuyu Pharma Inc stock valuation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.37x ₩9.30 Billion ₩24.95 Billion ₩7.30 Billion ▼ -97.9%
2023 17.93x ₩7.55 Billion ₩420.86 Million ₩5.11 Billion ▲ +1205.4%
2021 1.37x ₩6.19 Billion ₩4.51 Billion ₩6.07 Billion ▲ +108.6%
2019 0.66x ₩8.68 Billion ₩13.19 Billion ₩8.06 Billion ▼ -59.2%
2018 1.61x ₩9.87 Billion ₩6.11 Billion ₩9.76 Billion ▼ -83.4%
2017 9.74x ₩5.46 Billion ₩561.35 Million ₩5.19 Billion ▲ +2433.5%
2016 0.38x ₩3.77 Billion ₩9.82 Billion ₩2.32 Billion ▼ -80.8%
2014 2.00x ₩2.73 Billion ₩1.36 Billion ₩404.37 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow